GLP-1 receptor agonists, the class of drugs that includes semaglutide and similar medications now widely prescribed for diabetes and weight loss, have been linked in recent analyses to a lower rate of ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized the treatment of type 2 diabetes and obesity. However, for many users, the benefits of weight loss and blood sugar management come ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

Moderate exercise benefits GI health by improving motility, reducing constipation, and supporting gut health through neuroendocrine changes and increased vagal tone. High-intensity exercise can cause ...